CoChat

Link Between DYRK1A Overexpression and Several-Fold Enhancement of Neurofibrillary Degeneration With 3-Repeat Tau Protein in Down Syndrome

Open access
Wegiel, Jerzy, Kaczmarski, Wojciech, Barua, Madhabi, Kuchna, Izabela, Nowicki, Krzysztof, Wang, Kuo-Chiang, Wegiel, Jarek, Yang Ma, Shuang, Frackowiak, Janusz, Mazur-Kolecka, Bozena, Silverman, Wayne P., Reisberg, Barry, Monteiro, Isabel, de Leon, Mony, Wisniewski, Thomas, Dalton, Arthur, Lai, Florence, Hwang, Yu-Wen, Adayev, Tatyana, Liu, Fei, Iqbal, Khalid, Iqbal, Inge-Grundke, Gong, Cheng-Xin · 2011 · Journal of Neuropathology & Experimental Neurology
Cited by 98

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Triplication of chromosome 21 in Down syndrome (DS) results in overexpression of the minibrain kinase/dual-specificity tyrosine phosphorylated and regulated kinase 1A gene (DYRK1A). DYRK1A phosphorylates cytoplasmic tau protein and appears in intraneuronal neurofibrillary tangles (NFTs). We have previously shown significantly more DYRK1A-positive NFTs in DS brains than in sporadic Alzheimer disease (AD) brains. This study demonstrates a gene dosage-proportional increase in the level of DYRK1A in DS in the cytoplasm and the cell nucleus, and enhanced cytoplasmic and nuclear immunoreactivity of DYRK1A in DS. The results suggest that overexpressed DYRK1A may alter both phosphorylation of tau and alternative splicing factor (ASF). Two-dimensional electrophoresis revealed modification of ASF phosphorylation in DS/AD and AD in comparison to controls. Altered phosphorylation of ASF by overexpressed nuclear DYRK1A may contribute to the alternative splicing of the tau gene and an increase by 2.68 × of the 3R/4R ratio in DS/AD, and a several-fold increase in the number of 3R tau-positive NFTs in DS/AD subjects compared with that in sporadic AD subjects. These data support the hypothesis that phosphorylation of ASF by overexpressed DYRK1A may contribute to alternative splicing of exon 10, increased expression of 3R tau, and early onset of neurofibrillary degeneration in DS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/nen.0b013e318202bfa1

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 98

Metadata

Authors
Wegiel, J., Kaczmarski, W., Barua, M., Kuchna, I., Nowicki, K., Wang, K.-C., Wegiel, J., Yang Ma, S., Frackowiak, J., Mazur-Kolecka, B., Silverman, W. P., Reisberg, B., Monteiro, I., de Leon, M., Wisniewski, T., Dalton, A., Lai, F., Hwang, Y.-W., Adayev, T., Liu, F., Iqbal, K., Iqbal, I.-G., & Gong, C.-X.
Venue
Journal of Neuropathology & Experimental Neurology
Published
2011-01
Volume
70
Issue
1
Pages
36-50
ISSN
  • 0022-3069 (ISSN-L)
  • 1554-6578
OpenAlex
W2017062009
Cited by
98
References
30
FWCI
3.23
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Link Between DYRK1A Overexpression and Several-Fold Enhancement of Neurofibrillary Degeneration With 3-Repeat Tau Protein in Down Syndrome. https://app.cochat.ai/papers/10.1097/nen.0b013e318202bfa1
The paper
Wegiel, J., Kaczmarski, W., Barua, M., Kuchna, I., Nowicki, K., Wang, K.-C., Wegiel, J., Yang Ma, S., Frackowiak, J., Mazur-Kolecka, B., Silverman, W. P., Reisberg, B., Monteiro, I., de Leon, M., Wisniewski, T., Dalton, A., Lai, F., Hwang, Y.-W., Adayev, T., . . . Gong, C.-X. (2011). Link Between DYRK1A Overexpression and Several-Fold Enhancement of Neurofibrillary Degeneration With 3-Repeat Tau Protein in Down Syndrome. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1097/nen.0b013e318202bfa1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.